Kyle LaHucik

Articles by Kyle LaHucik

Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B - Endpoints News

Business May 13, 2026

Its beΒ­comΒ­ing HenΒ­grui PharΒ­mas world, and some WestΒ­ern drugΒ­makΒ­ers are just livΒ­ing in it. ChiΒ­nas largest pharΒ­ma comΒ­paΒ­ny, which boasts one of the biggest pipelines

Exclusive: Mediar gains $76M for clinical trials of three fibrosis drugs - Endpoints News

Health January 8, 2026

A fiΒ­broΒ­sis biotech has reeled in $76 milΒ­lion to get clinΒ­iΒ­cal daΒ­ta on three exΒ­perΒ­iΒ­menΒ­tal medΒ­iΒ­cines over the next two years. MeΒ­diΒ­ar TherΒ­aΒ­peuΒ­tics raised the